InvestorsHub Logo
Followers 24
Posts 2696
Boards Moderated 0
Alias Born 04/21/2012

Re: None

Tuesday, 01/14/2014 10:27:00 AM

Tuesday, January 14, 2014 10:27:00 AM

Post# of 130505
"Amarantus picked up eltoprazine cheap, only paying $100,000 to PGI Drug Discovery. PGI Drug Discovery has recently made the decision to partner its clinical drug candidates and focus future efforts on the CRO business. The deal was no-doubt brokered by former PsychoGenics Chief Scientific Officer and current Amarantus Board member, David A. Lowe, PhD."
From Seeking Alpha article.